COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 717: Articles 7161-7170  | Next

Covid-19 is a leading cause of death in children and young people ages 0-19 years in the United States
Flaxman, S., Whittaker, C., Semenova, E., Rashid, T., Parks, R., Blenkinsop, A., Unwin, H. J. T., Mishra, S., Bhatt, S., Gurdasani, D., Ratmann, O.
10.1101/2022.05.23.22275458 — Posted: 2022-05-25
Measuring Community Resilience During the COVID-19 based on Community Wellbeing and Resource Distribution
Valinejad, J., Guo, Z., Cho, J.-H., Chen, I.-R.
10.1101/2022.05.23.22275454 — Posted: 2022-05-25
Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5
Willett, B. J., Kurshan, A., Thakur, N., Newman, J., Manali, M., Tyson, G., Logan, N., Murcia, P. R., Snell, L. B., Edgeworth, J. D., Zhou, J., Sukhova, K., Amirthalingam, G., Brown, K., Charleston, B., Malim, M. H., Thomson, E. C., Barclay, W. S., Bailey, D., Doores, K. J., Peacock, T. P.
10.1101/2022.05.25.493397 — Posted: 2022-05-25
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
Hemmi, T., Ainai, A., Hashiguchi, T., Tobiume, M., Kanno, T., Iwata-Yoshikawa, N., Iida, S., Sato, Y., Miyamoto, S., Ueno, A., Sano, K., Saito, S., Shiwa-Sudo, N., Nagata, N., Tamura, K., Suzuki, R., Hasegawa, H., Suzuki, T.
10.1101/2022.05.24.493348 — Posted: 2022-05-25
Evaluation of triage checklist for mild COVID-19 outpatients in predicting subsequent emergency department visits and hospitalization during isolation period
Tanaka, Y., Yamamoto, K., Morimoto, S., Nabeshima, T., Matsushima, K., Ishimoto, H., Ashizawa, N., Hirayama, T., Takeda, K., Gyotoku, H., Iwanaga, N., Takemoto, S., Fukahori, S., Takazono, T., Yamaguchi, H., Kido, T., Sakamoto, N., Hosogaya, N., Akabame, S., Sugimoto, T., Yamanashi, H., Matsui, K., Izumida, M., Fujita, A., Tashiro, M., Tanaka, T., Ariyoshi, K., Furumoto, A., Morita, K., Izumikawa, K., Yanagihara, K., Mukae, H.
10.1101/2022.05.23.22275444 — Posted: 2022-05-25
Depressive and anxiety symptoms during the COVID-19 pandemic: A two-year follow-up
Bu, F., Steptoe, A., Fancourt, D.
10.1101/2022.05.24.22275529 — Posted: 2022-05-25
Hemin shows antiviral activity in vitro, possibly through suppression of viral entry mediators.
UNAL, M. A., BITIRIM, C. V., SOMERS, J., SUMMAK, G. Y., BUL BESBINAR, O., KOCAKAYA, E., GURCAN, C., NAZIR, H., Aksoy Ozer, Z. B., OZKAN, S. A., BEREKETOGLU, S., OZKUL, A., DEMIR, E., AKCALI, K. C., YILMAZER, A.
10.1101/2022.05.24.493187 — Posted: 2022-05-25
Initial protection against Omicron in children and adolescents by BNT162b2
Amir, O., Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Ash, N., Alroy-Preis, S., Huppert, A., Milo, R.
10.1101/2022.05.22.22275323 — Posted: 2022-05-25
Humoral Immunity to SARS-CoV-2 and Inferred Protection from Infection in a French Longitudinal Community Cohort
Woudenberg, T., Pinaud, L., Garcia, L., Tondeur, L., Pelleau, S., de Thoisy, A., Donnadieu, F., Backovic, M., Attia, M., Hoze, N., Duru, C., Koffi, A. D., Castelain, S., Ungeheuer, M.-N., Fernandes Pellerin, S., Planas, D., Bruel, T., CAUCHEMEZ, S., Schwarz, O., Fontanet, A., White, M.
10.1101/2022.05.23.22275460 — Posted: 2022-05-25
Diagnostic accuracy of the Panbio COVID-19 Antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation
Irungu, J. K., Munyua, P., Ochieng, C., Juma, B., Amoth, P., Kuria, F., Kiiru, J., Makayotto, L., Abade, A., Bulterys, M., Hunsperger, E., Emukule, G. O., Onyango, C., Samandari, T., Barr, B. A. T., Akelo, V., Weyenga, H., Munywoki, P. K., Bigogo, G., Otieno, N. A., Kisivuli, J. A., Ochieng, E., Nyaga, R., Hull, N., Herman-Roloff, A., Aman, R.
10.1101/2022.05.23.22275439 — Posted: 2022-05-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).